Bosulif
Manufacturing · Kansas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
PO Box 29387, Mission, Kansas, 66201, Un...Phone Number
(877) 744-5675Website
www.bosulif.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Bosulif
Bosulif is a prescription medication developed to treat chronic phase Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML) in adults and children aged one year and older, particularly for those who are newly diagnosed or who have not benefitted from other treatments. It belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs), which work by inhibiting BCR-ABL function to slow the growth of leukemia cells. The company also provides support resources, including a patient financial assistance program and the MyTherapy App, designed to help patients manage their treatment effectively. Bosulif is intended for patients experiencing specific phases of Ph+ CML and is crucial for healthcare professionals to monitor the proper usage and effectiveness of the medication.Explore more
Popular SearchesBosulifPfizer IncSIC Code 28,283NAICS Code 32,325Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Bosulif your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Bosulif is spiking on competitors!
Product Launch: Get notified when Bosulif launches new products
Check if Bosulif has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Bosulif recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Bosulif has new funding data
Congratulate Masked Content for being promoted to Masked Content at Bosulif
Bosulif, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Bosulif had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Bosulif
Compare insights from companies similar to Bosulif, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Bosulif
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Bosulif is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Bosulif is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Bosulif.
Bosulif Tech Stack
A closer look at the technologies used by Bosulif
Bosulif News & Media
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Bosulif
Sign Up For FreeTo access detailed company insights
Bosulif is a prescription medication developed to treat chronic phase Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML) in adults and children aged one year and older, particularly for those who are newly diagnosed or who have not benefitted from other treatments. It belongs to a class of drugs known as tyrosine kinase inhibit... Read More
